+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2026-2032- Product Image
AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2026-2032- Product Image
Sale

AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6127172
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The AI-driven Peptide Drug Discovery Platform Market is projected to reach USD 1.21 Billion in 2026. It is expected to continue growing at a CAGR of 12.29%, reaching USD 2.44 Billion by 2032.

AI-Driven Peptide Drug Discovery Platforms: Executive Overview

AI-driven peptide drug discovery platforms combine machine learning, generative modeling, bioinformatics, structural prediction, and laboratory automation to identify and optimize peptide candidates. Their value lies in accelerating sequence design, improving target selection, prioritizing experiments, and supporting more systematic analysis of activity, selectivity, stability, delivery, and manufacturability. Adoption depends on scientific validation, access to high-quality data, laboratory integration, regulatory readiness, and the ability to translate computational results into reproducible biological outcomes.

From Sequential Screening to Integrated, Data-Centered Discovery

The landscape is shifting from largely sequential screening toward integrated workflows that connect target biology, peptide generation, computational scoring, synthesis, testing, and iterative model refinement. Advances in protein-structure analysis, multimodal datasets, active learning, and automated experimentation are enabling researchers to test fewer but more strategically selected candidates. At the same time, challenges remain around biased training data, limited assay comparability, peptide degradation, cell permeability, immunogenicity, and the need to demonstrate experimental reproducibility across laboratories.

Artificial Intelligence Is Strengthening Design, Prioritization, and Learning Loops

Artificial intelligence is contributing most directly through sequence generation, property prediction, virtual screening, de novo design, structure-informed optimization, and analysis of experimental results. Its cumulative impact increases when models are connected to standardized assays and automated or semi-automated laboratories, allowing closed-loop learning rather than one-time prediction. Human expertise remains essential for defining biologically meaningful objectives, assessing translational risks, interpreting uncertain outputs, and ensuring that model recommendations comply with research-quality and regulatory expectations.

Regional Dynamics Reflect Research Capacity, Regulation, and Biomanufacturing Readiness

North America benefits from established biomedical research networks, advanced biotechnology infrastructure, and strong links between computational science and translational development. Europe combines sophisticated academic research with coordinated regulatory and data-governance frameworks, while Asia-Pacific is supported by expanding life-science capabilities, substantial research populations, and growing investment in automation and artificial intelligence. The Middle East is developing innovation ecosystems and research infrastructure, and Africa is building capabilities unevenly around academic, public-health, and biotechnology priorities. Latin America shows growing interest in computational drug discovery, with adoption shaped by research funding, access to specialized infrastructure, and collaboration with international institutions.

Cross-Border Groups Shape Standards, Funding, and Technology Access

ASEAN countries are strengthening regional scientific collaboration while addressing varied levels of digital infrastructure and biotechnology capacity. BRICS members bring substantial research populations, manufacturing capabilities, and public-sector science programs, but differ in data governance and platform maturity. The European Union emphasizes coordinated research, privacy, regulatory alignment, and interoperable scientific data. G7 economies generally combine advanced computational resources with mature pharmaceutical and academic ecosystems. GCC countries are prioritizing technology-enabled healthcare and research diversification, while NATO members contribute extensive biomedical, security, and dual-use research networks that can support advanced analytics and resilient data infrastructure.

Country-Level Capabilities Vary Across Research, Data, and Translation

The United States and Canada offer strong foundations in artificial intelligence, biomedical research, and translational partnerships. The United Kingdom, Germany, France, Italy, and Spain combine established life-science institutions with active European research and regulatory collaboration. China, Japan, South Korea, India, and Australia are expanding capabilities in computational biology, biotechnology, and laboratory automation, with distinct approaches to data governance and commercialization. Brazil and Mexico are advancing research and innovation ecosystems while managing infrastructure and funding constraints. Russia retains scientific capabilities in selected fields, although access to international collaboration, equipment, and data may affect platform development and validation.

Build Trustworthy, Experiment-Linked Platforms Before Scaling Deployment

Industry leaders should prioritize high-quality, well-annotated peptide and assay datasets; establish common data standards; and document model performance across diverse targets and experimental settings. Platforms should connect prediction with synthesis and testing, use uncertainty estimates to guide experimental selection, and include explicit evaluation of stability, toxicity, immunogenicity, delivery, and manufacturability. Organizations should also create cross-functional governance spanning computational science, medicinal chemistry, biology, clinical development, quality, and regulatory affairs. Regional partnerships, secure data-sharing arrangements, and workforce development can improve access while reducing duplication and strengthening reproducibility.

Methodology: Evidence-Based Assessment of Technology and Adoption Conditions

This executive summary uses a structured qualitative assessment of the AI-driven peptide drug discovery platform landscape. The approach considers platform functionality, discovery-workflow integration, data requirements, experimental validation, regulatory and ethical considerations, research infrastructure, and regional ecosystem conditions. Regional, group, and country perspectives are synthesized from the specified geographies and interpreted through publicly documented patterns in biotechnology capacity, artificial intelligence research, pharmaceutical development, data governance, and scientific collaboration. No market estimates, market shares, forecasts, or company-specific claims are used.

The Platforms with the Strongest Scientific Feedback Loops Will Lead Adoption

AI-driven peptide drug discovery platforms are moving toward integrated systems in which computation and experimentation continuously inform one another. Sustainable progress will depend less on algorithmic novelty alone than on validated data, transparent performance assessment, laboratory connectivity, and disciplined translation into therapeutic development. Leaders that combine responsible artificial intelligence with strong biological insight, robust quality systems, and regionally informed collaboration will be best positioned to convert faster design cycles into credible drug-discovery outcomes.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. AI-driven Peptide Drug Discovery Platform Market, by Technology Type
7.1. Introduction
7.2. Cloud Based Platform
7.2.1. Hybrid Cloud
7.2.2. Private Cloud
7.2.3. Public Cloud
7.3. Deep Learning Platform
7.3.1. Convolutional Neural Network
7.3.2. Graph Neural Network
7.3.3. Recurrent Neural Network
7.4. Machine Learning Platform
7.4.1. Reinforcement Learning
7.4.2. Supervised Learning
7.4.3. Unsupervised Learning
7.5. On Premise Platform
7.5.1. Conventional Hpc
7.5.2. Dedicated Servers
8. AI-driven Peptide Drug Discovery Platform Market, by Therapeutic Application
8.1. Introduction
8.2. Cardiovascular
8.2.1. Atherosclerosis
8.2.2. Heart Failure
8.3. Infectious Diseases
8.3.1. Bacterial
8.3.2. Viral
8.4. Metabolic Disorders
8.4.1. Diabetes
8.4.2. Obesity
8.5. Neurological
8.5.1. Alzheimers
8.5.2. Parkinsons
8.6. Oncology
8.6.1. Hematological Malignancies
8.6.2. Solid Tumors
9. AI-driven Peptide Drug Discovery Platform Market, by Peptide Class
9.1. Introduction
9.2. Cyclic Peptides
9.2.1. Head To Tail
9.2.2. Side Chain To Side Chain
9.3. Linear Peptides
9.3.1. Long Peptides
9.3.2. Short Peptides
9.4. Peptidomimetics
9.4.1. Beta Peptides
9.4.2. Peptoids
10. AI-driven Peptide Drug Discovery Platform Market, by End User
10.1. Introduction
10.2. Academic & Government Research Institutes
10.2.1. Private Research Institutes
10.2.2. Public Research Institutes
10.3. Contract Research Organizations
10.3.1. Large Cro Organizations
10.3.2. Small Cro Organizations
10.4. Pharmaceutical & Biotechnology Companies
10.4.1. Biotechnology Companies
10.4.2. Pharmaceutical Companies
11. AI-driven Peptide Drug Discovery Platform Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. AI-driven Peptide Drug Discovery Platform Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. AI-driven Peptide Drug Discovery Platform Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Atombeat, Inc.
15.2. Aurigene Discovery Technologies Limited
15.3. Cradle, Inc.
15.4. Creative Peptides, Inc.
15.5. Deep Genomics Inc.
15.6. DenovAI Biotech, Inc.
15.7. Fujitsu Limited
15.8. Generate Biomedicines, Inc.
15.9. Gubra ApS
15.10. Iktos SA
15.11. Insilico Medicine, Inc.
15.12. Koliber Biosciences, Inc.
15.13. Numerion Labs, Inc.
15.14. Nuritas Limited
15.15. Pepticom, Inc.
15.16. Peptilogics, Inc.
15.17. Relay Therapeutics, Inc.
15.18. Space Peptides, Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global AI-driven Peptide Drug Discovery Platform Market, Years Considered for the Study
FIGURE 2. Global AI-driven Peptide Drug Discovery Platform Market, Research Design
FIGURE 3. Global AI-driven Peptide Drug Discovery Platform Market, Research Framework
FIGURE 4. Global AI-driven Peptide Drug Discovery Platform Market, Data Triangulation
FIGURE 5. Global AI-driven Peptide Drug Discovery Platform Market Size, 2017-2032 (USD Million)
FIGURE 6. Global AI-driven Peptide Drug Discovery Platform Market Size, by Technology Type, 2025 vs 2032 (%)
FIGURE 7. Global AI-driven Peptide Drug Discovery Platform Market Size, by Technology Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global AI-driven Peptide Drug Discovery Platform Market Size, by Therapeutic Application, 2025 vs 2032 (%)
FIGURE 9. Global AI-driven Peptide Drug Discovery Platform Market Size, by Therapeutic Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global AI-driven Peptide Drug Discovery Platform Market Size, by Peptide Class, 2025 vs 2032 (%)
FIGURE 11. Global AI-driven Peptide Drug Discovery Platform Market Size, by Peptide Class, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global AI-driven Peptide Drug Discovery Platform Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global AI-driven Peptide Drug Discovery Platform Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global AI-driven Peptide Drug Discovery Platform Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global AI-driven Peptide Drug Discovery Platform Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global AI-driven Peptide Drug Discovery Platform Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global AI-driven Peptide Drug Discovery Platform Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global AI-driven Peptide Drug Discovery Platform Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global AI-driven Peptide Drug Discovery Platform Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global AI-driven Peptide Drug Discovery Platform Market Segmentation & Coverage
TABLE 2. Global AI-driven Peptide Drug Discovery Platform Market Size, 2017-2032 (USD Million)
TABLE 3. Global AI-driven Peptide Drug Discovery Platform Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 4. Global Cloud Based Platform Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cloud Based Platform Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cloud Based Platform Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Hybrid Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Hybrid Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Hybrid Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Private Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Private Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Private Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Public Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Public Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Public Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Deep Learning Platform Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Deep Learning Platform Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Deep Learning Platform Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Convolutional Neural Network Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Convolutional Neural Network Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Convolutional Neural Network Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Graph Neural Network Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Graph Neural Network Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Graph Neural Network Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Recurrent Neural Network Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Recurrent Neural Network Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Recurrent Neural Network Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Machine Learning Platform Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Machine Learning Platform Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Machine Learning Platform Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Reinforcement Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Reinforcement Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Reinforcement Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Supervised Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Supervised Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Supervised Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Unsupervised Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Unsupervised Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Unsupervised Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global On Premise Platform Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global On Premise Platform Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global On Premise Platform Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Conventional Hpc Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Conventional Hpc Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Conventional Hpc Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Dedicated Servers Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Dedicated Servers Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Dedicated Servers Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global AI-driven Peptide Drug Discovery Platform Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 50. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Atherosclerosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Atherosclerosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Atherosclerosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Heart Failure Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Heart Failure Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Heart Failure Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Bacterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Bacterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Bacterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Viral Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Viral Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Viral Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Metabolic Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Metabolic Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Metabolic Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Diabetes Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Diabetes Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Diabetes Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Obesity Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Obesity Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Obesity Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Neurological Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Neurological Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Neurological Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Alzheimers Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Alzheimers Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Alzheimers Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Parkinsons Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Parkinsons Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Parkinsons Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Hematological Malignancies Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Hematological Malignancies Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Hematological Malignancies Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Solid Tumors Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Solid Tumors Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Solid Tumors Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global AI-driven Peptide Drug Discovery Platform Market Size, by Peptide Class, 2017-2032 (USD Million)
TABLE 96. Global Cyclic Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Cyclic Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Cyclic Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Head To Tail Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Head To Tail Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Head To Tail Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Side Chain To Side Chain Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Side Chain To Side Chain Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Side Chain To Side Chain Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Linear Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Linear Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Linear Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Long Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Long Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Long Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Short Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Short Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Short Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Peptidomimetics Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Peptidomimetics Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Peptidomimetics Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Beta Peptides Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Beta Peptides Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Beta Peptides Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Peptoids Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Peptoids Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Peptoids Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global AI-driven Peptide Drug Discovery Platform Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. Global Academic & Government Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Academic & Government Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Academic & Government Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Private Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Private Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Private Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Public Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Public Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Public Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Large Cro Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Large Cro Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Large Cro Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Small Cro Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Small Cro Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Small Cro Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global AI-driven Peptide Drug Discovery Platform Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Cloud Based Platform, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Deep Learning Platform, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Machine Learning Platform, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by On Premise Platform, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Peptide Class, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Cyclic Peptides, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Linear Peptides, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Peptidomimetics, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Academic & Government Research Institutes, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 172. North America AI-driven Peptide Drug Discovery Platform Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. North America AI-driven Peptide Drug Discovery Platform Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 174. North America AI-driven Peptide Drug Discovery Platform Market Size, by Cloud Based Platform, 2017-2032 (USD Million)
TABLE 175. North America AI-driven Peptide Drug Discovery Platform Market Size, by Deep Learning Platform, 2017-2032 (USD Million)
TABLE 176. North America AI-driven Peptide Drug Discovery Platform Market Size, by Machine Learning Platform, 2017-2032 (USD Million)
TABLE 177. North America AI-driven Peptide Drug Discovery Platform Market Size, by On Premise Platform, 2017-2032 (USD Million)
TABLE 178. North America AI-driven Peptide Drug Discovery Platform Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 179. North America AI-driven Peptide Drug Discovery Platform Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 180. North America AI-driven Peptide Drug Discovery Platform Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 181. North America AI-driven Peptide Drug Discovery Platform Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 182. North America AI-driven Peptide Drug Discovery Platform Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 183. North America AI-driven Peptide Drug Discovery Platform Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 184. North America AI-driven Peptide Drug Discovery Platform Market Size, by Peptide Class, 2017-2032 (USD Million)
TABLE 185. North America AI-driven Peptide Drug Discovery Platform Market Size, by Cyclic Peptides, 2017-2032 (USD Million)
TABLE 186. North America AI-driven Peptide Drug Discovery Platform Market Size, by Linear Peptides, 2017-2032 (USD Million)
TABLE 187. North America AI-driven Peptide Drug Discovery Platform Market Size, by Peptidomimetics, 2017-2032 (USD Million)
TABLE 188. North America AI-driven Peptide Drug Discovery Platform Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. North America AI-driven Peptide Drug Discovery Platform Market Size, by Academic & Government Research Institutes, 2017-2032 (USD Million)
TABLE 190. North America AI-driven Peptide Drug Discovery Platform Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 191. North America AI-driven Peptide Drug Discovery Platform Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 192. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Region, 2017-2032 (USD Million)
TABLE 193. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 194. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Cloud Based Platform, 2017-2032 (USD Million)
TABLE 195. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Deep Learning Platform, 2017-2032 (USD Million)
TABLE 196. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Machine Learning Platform, 2017-2032 (USD Million)
TABLE 197. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by On Premise Platform, 2017-2032 (USD Million)
TABLE 198. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 199. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 200. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 201. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 202. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 203. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 204. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Peptide Class, 2017-2032 (USD Million)
TABLE 205. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Cyclic Peptides, 2017-2032 (USD Million)
TABLE 206. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Linear Peptides, 2017-2032 (USD Million)
TABLE 207. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Peptidomimetics, 2017-2032 (USD Million)
TABLE 208. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Academic & Government Research Institutes, 2017-2032 (USD Million)
TABLE 210. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 211. Latin America AI-driven Peptide Drug Discovery Platform Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 212. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Region, 2017-2032 (USD Million)
TABLE 213. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 214. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Cloud Based Platform, 2017-2032 (USD Million)
TABLE 215. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Deep Learning Platform, 2017-2032 (USD Million)
TABLE 216. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Machine Learning Platform, 2017-2032 (USD Million)
TABLE 217. Europe AI-driven Peptide Drug Discovery Platform Market Size, by On Premise Platform, 2017-2032 (USD Million)
TABLE 218. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 219. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 220. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 221. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 222. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 223. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 224. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Peptide Class, 2017-2032 (USD Million)
TABLE 225. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Cyclic Peptides, 2017-2032 (USD Million)
TABLE 226. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Linear Peptides, 2017-2032 (USD Million)
TABLE 227. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Peptidomimetics, 2017-2032 (USD Million)
TABLE 228. Europe AI-driven Peptide Drug Discovery Platform Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Academic & Government Research Institutes, 2017-2032 (USD Million)
TABLE 230. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 231. Europe AI-driven Peptide Drug Discovery Platform Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 232. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Region, 2017-2032 (USD Million)
TABLE 233. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 234. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Cloud Based Platform, 2017-2032 (USD Million)
TABLE 235. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Deep Learning Platform, 2017-2032 (USD Million)
TABLE 236. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Machine Learning Platform, 2017-2032 (USD Million)
TABLE 237. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by On Premise Platform, 2017-2032 (USD Million)
TABLE 238. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 239. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 240. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 241. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 242. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 243. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 244. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Peptide Class, 2017-2032 (USD Million)
TABLE 245. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Cyclic Peptides, 2017-2032 (USD Million)
TABLE 246. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Linear Peptides, 2017-2032 (USD Million)
TABLE 247. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Peptidomimetics, 2017-2032 (USD Million)
TABLE 248. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Academic & Government Research Institutes, 2017-2032 (USD Million)
TABLE 250. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 251. Middle East AI-driven Peptide Drug Discovery Platform Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 252. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Region, 2017-2032 (USD Million)
TABLE 253. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 254. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Cloud Based Platform, 2017-2032 (USD Million)
TABLE 255. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Deep Learning Platform, 2017-2032 (USD Million)
TABLE 256. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Machine Learning Platform, 2017-2032 (USD Million)
TABLE 257. Africa AI-driven Peptide Drug Discovery Platform Market Size, by On Premise Platform, 2017-2032 (USD Million)
TABLE 258. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 259. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 260. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 261. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 262. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 263. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 264. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Peptide Class, 2017-2032 (USD Million)
TABLE 265. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Cyclic Peptides, 2017-2032 (USD Million)
TABLE 266. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Linear Peptides, 2017-2032 (USD Million)
TABLE 267. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Peptidomimetics, 2017-2032 (USD Million)
TABLE 268. Africa AI-driven Peptide Drug Discovery Platform Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Academic & Government Research Institutes, 2017-2032 (USD Million)
TABLE 270. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 271. Africa AI-driven Peptide Drug Discovery Platform Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 272. Global AI-driven Peptide Drug Discovery Platform Market Size, by Group, 2017-2032 (USD Million)
TABLE 273. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Group, 2017-2032 (USD Million)
TABLE 274. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 275. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Cloud Based Platform, 2017-2032 (USD Million)
TABLE 276. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Deep Learning Platform, 2017-2032 (USD Million)
TABLE 277. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Machine Learning Platform, 2017-2032 (USD Million)
TABLE 278. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by On Premise Platform, 2017-2032 (USD Million)
TABLE 279. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 280. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 281. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 282. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 283. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 284. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 285. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Peptide Class, 2017-2032 (USD Million)
TABLE 286. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Cyclic Peptides, 2017-2032 (USD Million)
TABLE 287. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Linear Peptides, 2017-2032 (USD Million)
TABLE 288. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Peptidomimetics, 2017-2032 (USD Million)
TABLE 289. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Academic & Government Research Institutes, 2017-2032 (USD Million)
TABLE 291. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 292. ASEAN AI-driven Peptide Drug Discovery Platform Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032 (USD Million)
TABLE 293. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Group, 2017-2032 (USD Million)
TABLE 294. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Technology Type, 2017-2032 (USD Million)
TABLE 295. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Cloud Based Platform, 2017-2032 (USD Million)
TABLE 296. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Deep Learning Platform, 2017-2032 (USD Million)
TABLE 297. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Machine Learning Platform, 2017-2032 (USD Million)
TABLE 298. GCC AI-driven Peptide Drug Discovery Platform Market Size, by On Premise Platform, 2017-2032 (USD Million)
TABLE 299. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Therapeutic Application, 2017-2032 (USD Million)
TABLE 300. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 301. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Infectious Diseases, 2017-2032 (USD Million)
TABLE 302. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Metabolic Disorders, 2017-2032 (USD Million)
TABLE 303. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Neurological, 2017-2032 (USD Million)
TABLE 304. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 305. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Peptide Class, 2017-2032 (USD Million)
TABLE 306. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Cyclic Peptides, 2017-2032 (USD Million)
TABLE 307. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Linear Peptides, 2017-2032 (USD Million)
TABLE 308. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Peptidomimetics, 2017-2032 (USD Million)
TABLE 309. GCC AI-driven Peptide Drug Discovery Platform Market Size, by End User, 2017-2032 (USD Million)
TABLE 310. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Academic & Government Research Institutes, 2017-2032 (USD Million)
TABLE 311. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
TABLE 312. GCC AI-driven Peptide Drug Discovery Platform Market Size, by Pharmaceutical & Biotechnology Companies, 2017-2032

Companies Mentioned

  • Atombeat, Inc.
  • Aurigene Discovery Technologies Limited
  • Cradle, Inc.
  • Creative Peptides, Inc.
  • Deep Genomics Inc.
  • DenovAI Biotech, Inc.
  • Fujitsu Limited
  • Generate Biomedicines, Inc.
  • Gubra ApS
  • Iktos SA
  • Insilico Medicine, Inc.
  • Koliber Biosciences, Inc.
  • Numerion Labs, Inc.
  • Nuritas Limited
  • Pepticom, Inc.
  • Peptilogics, Inc.
  • Relay Therapeutics, Inc.
  • Space Peptides, Inc.

Related Topics

Related Reports

In-Silico Drug Discovery Market - Global Forecast 2026-2032 - Product Image

In-Silico Drug Discovery Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Peptoids Market - Global Forecast 2026-2032 - Product Image

Peptoids Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Peptide Drug Discovery Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Type (Therapeutic Peptides, Vaccine Peptides), Technology, Route of Administration, Application - Product Image

Peptide Drug Discovery Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Type (Therapeutic Peptides, Vaccine Peptides), Technology, Route of Administration, Application

  • Report
  • 160 Pages
  • Global
From
G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market Report 2026 - Product Image

G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.